Phosphatidylinositol-3-kinase (PI3K/AKT/mammalian target of rapamycin [mTOR]) is one of the most important intracellular pathways. It can be considered as the regulator of cancer. Dysregulation of this pathway is often implicated in chronic inflammatory diseases and is a key driver in the development and progression of various cancers. By exploring how this pathway can be modulated, we can gain insights into potential therapeutic strategies for managing these conditions.

Objectives:
What is AKT/PI3K Pathway?
What are the results of AKT/PI3K pathway activation?
What drugs and supplements can modulate this pathway?

Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
 

PI3K signalling in inflammation - ScienceDirect
https://www.sciencedirect.com/science/article/pii/S1388198114002583

AKT/PI3K Signaling Pathway | Rockland
https://www.rockland.com/resources/akt-pi3k-signaling-pathway/

PI3K/Akt/mTOR signaling pathway. PI3K signaling starts by the... | Download Scientific Diagram
https://www.researchgate.net/figure/PI3K-Akt-mTOR-signaling-pathway-PI3K-signaling-starts-by-the-activation-of-either-a_fig2_349706150

Targeting PI3K in cancer: mechanisms and advances in clinical trials | Molecular Cancer | Full Text
https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-019-0954-x

The PI3K/AKT pathway in obesity and type 2 diabetes - PMC
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158718/